Goa brings adult vaccination into a life-course policy
Goa has launched a life-course immunisation policy for 2026–2036. Its initial phase will offer influenza, pneumococcal and hepatitis B vaccines to at-risk adult groups.
Article subject labels can be suggestions and are not editorial confirmation.
Goa has launched a life-course immunisation policy for 2026–2036. Its initial phase will offer influenza, pneumococcal and hepatitis B vaccines to at-risk adult groups.
WHO says the five-day campaign targets children aged 9–59 months in all 146 districts and cities.
In CDC’s January–June simulations, median time to masking was 2 minutes and to isolation 11 minutes.
The Data to Action project is backed by a US$35.99 million grant, with additional partner co-financing reported above US$151 million.
ECDC’s 2 October update lists 202 affected areas in 16 countries through 30 September.
WHO estimates updated in July 2026 put new HIV infections at 1.2 million and HIV-related deaths at 570,000 in 2025.
WUENIC estimates put global three-dose DTP coverage at 85%, up one point; an estimated 13.5 million children received no vaccine.
New estimates show children under five carry a disproportionate foodborne disease burden relative to their population share.
WHO’s 2026 report estimates 1.34 million viral hepatitis deaths in 2024 and highlights gaps in diagnosis and treatment.
A joint WHO Europe–ECDC report found 2024 diagnoses covered 79% of estimated disease burden in the region.
ECDC preliminary data show reports from 30 countries fell from 2024 but remained about twice the 2023 level.
An analysis of 185 countries and 36 cancer types estimates about 7.1 million cases were linked to preventable risks.